Use of antisecretory drugs among consumers of non-steroidal anti-inflammatory drugs in the general population

Alimentary Pharmacology and Therapeutics

Volumn 24, Issue 11-12, 2006, Pages 1585-1592

  Rey, E ^a,d   Elola Olaso, C Morena ^a   Rodriguez Artalejo F ^b   Locke III, G R ^c   Diaz Rubio, M ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c MAYO CLINIC   (United States)

^d HOSPITAL CLÍNICO SAN CARLOS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; STOMACH SECRETION INHIBITOR;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CONSUMER; CONTROLLED STUDY; DIGESTIVE SYSTEM HEMORRHAGE; DIGESTIVE SYSTEM ULCER; DRUG USE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; SATIETY; SPAIN; STOMACH PROTECTION; SYMPTOMATOLOGY;

ADULT; AGED; ANTACIDS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DIGESTIVE SYSTEM DISEASES; DRUG COMBINATIONS; FEMALE; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; MIDDLE AGED; PROTON PUMPS; RISK FACTORS;

EID: 33845496973     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2006.03173.x     Document Type: Article

References (34)

1. Lanas A, Perez-Aisa MA, Feu F, et al. Investigators of the Asociacion Española de Gastroenterología. A nationwide study of mortality associated with hospital admission due to severe gastrointestinal events and those associated with nonsteroidal antiinflammatory drug use. Am J Gastroenterol 2005; 100: 1685-93.
2. Peura DA. Prevention of nonsteroidal antiinflammatory drug-associated gastrointestinal symptoms and ulcer complications. Am J Med 2004; 117 (Suppl. 5A): 63S-71S.
3. Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL. Underutilization of preventive strategies in patients receiving NSAIDs. Rheumatology 2003; 42 (Suppl. 3): iii23-31.
4. Micklewright R, Lane S, Linley W, McQuade C, Thompson F, Maskrey N. NSAIDs, gastroprotection and cyclooxygenase-II selective inhibitors. Aliment Pharmacol Ther 2003; 17: 321-32.
5. Laine L. Approaches to nonsteroidal anti-inflammatory drug use in the high risk patient. Gastroenterology 2001; 120: 594-606.
6. Lanza FL. A guideline for the treatment and prevention of NSAID-induced ulcers. Members of the Ad Hoc Committee on Practice Parameters of the American College of Gastroenterology. Am J Gastroenterol 1998; 93: 2037-46.
7. Rostom A, Dube C, Wells G, et al. Prevention of NSAID-induced gastroduodenal ulcers. Cochrane Database Syst Rev 2002; 4: cd002296.
8. Wolfe MM. Risk factors associated with the development of gastroduodenal ulcers due to the use of NSAIDs. Int J Clin Pract Suppl 2003; 135: 32-7.
9. Lanas A. Impacto económico de los efectos secundarios gastrointestinales asociados a AINES en el Servicio Nacional de Salud. Med Clin (Barc) 2000; 114 (Suppl. 3): 46-53.
10. Sturkenboom MC, Romano F, Simon G, et al. The iatrogenic costs of NSAID therapy: a population study. Arthritis Rheum 2002; 47: 132-40.
11. Hartnell NR, Flanagan PS, MacKinnon NJ, Bakowsky VS. Use of gastrointestinal preventive therapy among elderly persons receiving antiarthritic agents in Nova Scotia, Canada. Am J Geriatr Pharmacother 2004; 2: 171-80.
12. Herings RM, Goettsch WG. Inadequate prevention of NSAID-induced gastrointestinal events. Ann Pharmacother 2004; 38: 760-3.
13. Helin-Salmivaara A, Huupponen R, Virtanen A, Lammela J, Klaukka T. Frequent prescribing of drugs with potential gastrointestinal toxicity among continuous users of non-steroidal antiinflammatory drugs. Eur J Clin Pharmacol 2005; 61: 425-31.
14. Clinard F, Bardou M, Sgro C, et al. Nonsteroidal antiinflammatory and cytoprotective drug co-prescription in general practice. A general practitioner-based survey in France. Eur J Clin Pharmacol 2001; 57: 737-43.
15. Sturkenboom MC, Burke TA, Tangelder MJ, Dieleman JP, Walton S, Goldstein JL. Adherence to proton pump inhibitors or H2-receptor antagonist during the use of non-steroidal antiinflammatory drugs. Aliment Pharmacol Ther 2003; 18: 1137-47.
16. Wilcox CM, Cryer B, Triadafilopoulos G. Patterns of use and public perception of over-the-counter pain relievers: focus on nonsteroidal antiinflammatory drugs. J Rheumatol 2005; 32: 2218-24.
17. Paulose-Ram R, Hirch R, Dillon C, Gu Q. Frequent monthly use of selected non-prescription and prescription non-narcotic analgesics among U.S. adults. Pharmacoepidemiol Drug Saf 2005; 14: 257-66.
18. Díaz-Rubio M, Moreno-Elola-Olaso C, Rey E, Locke GR III, Rodríguez-Artalejo F. Symptoms of gastro-oesophageal reflux: prevalence, severity, duration and associated factors in the population of Spain. Aliment Pharmacol Ther 2004; 19: 95-105.
19. Locke GR, Talley NJ, Weaver AL, Zinsmeister AR. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69: 539-47.
20. Locke GR, Talley NJ, Fett SL, Zinsmeister AR, Melton LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112: 1448-56.
21. Moreno Elola-Olaso C, Rey E, Rodríguez-Artalejo F, Locke GR III, Díaz-Rubio M. Adaptation and validation of a gastroesophageal reflux questionnaire for use on a Spanish population. Rev Esp Enferm Dig 2002; 94: 745-51.
22. Rey E, Moreno-Elola-Olaso C, Rodriguez Artalejo F, Diaz-Rubio M. Medical consultation for gastro-oesophageal symptoms: reasons and associated factors. Digestion 2004; 70: 173-7.
23. Rey E, Moreno Elola-Olaso C, Locke GR III, Rodríguez-Artalejo F, Díaz-Rubio M. Association between weight gain and symptoms of gastroesophageal reflux in the general population. Am J Gastroenterol 2006; 101: 229-33.
24. Rey E, Moreno Elola-Olaso C, Rodríguez-Artalejo F, Locke GR III, Díaz-Rubio M. Prevalence of atypical symptoms and their association with typical symptoms of gastroesophageal reflux, in Spain. Eur J Gastroenterol Hepatol 2006; 18: 969-75.
25. Spanish National Health System. Grupos terapéuticos y principios activos de mayor consumo en el Sistema Nacional de Salud durante 2000. Información Terapéutica del Sistema Nacional de Salud 2001; 25: 78-82.
26. Lanas A, Martín Mola E, Ponce J, Navarro F, Piqué JM, Blanco JF. Estrategia clínica para la prevención de los efectos adversos sobre el tracto digestivo de antiinflamatorios no esteroideos. Recomendaciones de la Asociación Española de Gastroenterología y de la Sociedad Española de Reumatología. Gastroenterol Hepatol 2003; 26: 485-502.
27. Abraham NS, El-Serag HB, Johnson ML, et al. National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology 2005; 129: 1171-8.
28. Lanas A. Prevention and treatment of NSAID-induced gastroduodenal injury. Curr Treat Options Gastroenterol 2006; 9: 147-56.
29. Veldhuyzen van Zanten SJ, Bradette M, Chiba N, et al. Evidence-based recommendations for short- and long-term management of uninvestigated dyspepsia in primary care: an update of the Canadian Dyspepsia Working Group (CanDys) clinical management tool. Can J Gastroenterol 2005; 19: 285-303.
30. Singh G, Triadafilopoulos G. Appropriate choice of proton pump inhibitor therapy in the prevention and management of NSAID-related gastrointestinal damage. Int J Clin Pract 2005; 59: 1210-7.
31. Prodigy Knowledge (2006) Nonsteroideal Anti-Inflammatory Drugs (NSAIDs). SowerbyCentreforHealthInformaticsat-Newcastle. http://www.prodigy.nhs.uk/ ProdigyKnowledge/Guidance/Whole-GuidanceView.aspx?GuidanceId=37432 (access date June 27, 2006)
32. Burrull M, Madrilejos R, Gregori A, Busquets E. Antiinflamatorios no esteroides y protección gastrointestinal: 'prescripción adecuada en Atención Primaria?. Rev Esp Reumatol 2002; 29: 300-7.
33. Arboleya L, Figuera E, Soledad García M, Aragón B, Grupo estudio VICOXX. Tratamiento sintomático de la artrosis: Patrón de utilización de antiinflamatorios no esteroideos en los centros de salud españoles. Aten Primaria 1996; 18: 300-7.
34. Carvajal A, Arias LH, Vega E, Sánchez JA, Rodríguez IM, Ortega P, Pozo JG. Gastroprotection during the administration of non-steroidal inflammatory drugs. A drug-utilization study. Eur J Clin Pharmacol 2004; 60: 439-44.